LekoskopLekoskop
UK · ES · FR · CS · IT · NL · CH · HR · PL

Medicine recalls, shortages and safety updates in the UK

MHRA medicines recalls and defect notifications with batch numbers, Serious Shortage Protocols, new approvals and Drug Safety Update — updated daily, automatically. Last updated: 6 Oct 2026 08:50.

All Recalls and defects3 Serious shortages (SSP)2 New approvals1 Drug Safety Update

Sources: we track changes based on information published by the MHRA — medicines recalls and defect notifications, Drug Safety Update and approval announcements — and the Serious Shortage Protocols published by the NHS Business Services Authority. The UK is outside the EU, so European Commission decisions are not listed here.

expand all dayscollapse all days

17 Dec 2025Wednesday 17 December 2025

open day ◀ ▶ 1 event · 1 important
Drug Safety Update Rybelsus ® (semaglutide tablets)
There is a risk of patient harm arising through medication error during a transition period where the original and new formulation of Rybelsus ® tablets, which have different stated mg doses but are b…
What this means, batches, details

Loading…

Drug Safety Update on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency

15 Dec 2025Monday 15 December 2025

open day ◀ ▶ 1 event · 1 important
Medicines recall Prednisolone 5mg Soluble Tablets
Class 3 recall · DMRC-37820855 · PL: 28444/0276 · Activase Pharmaceuticals Limited · prednisolone sodium phosphate
Batches: 2409006 (31/05/2027), 2409007 (31/05/2027)
What this means, batches, details

Loading…

MHRA alert on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency

11 Dec 2025Thursday 11 December 2025

open day ◀ ▶ 1 event · 1 important
Medicines recall Clarithromycin 500 mg powder for concentrate for solution for infusion
Class 2 recall · DMRC-37790612 · PL: 01502/0135 · Hameln Pharma ltd · clarithromycin lactobionate
Batches: 23J097 (30/09/2027), 23J098 (30/09/2027), 23J099 (30/09/2027), 23J100 (30/09/2027), 24A227 (30/11/2027), 24A230 (31/12/2027), 24E038 (31/01/2028), 24E039 (29/02/2028), 24E040 (29/02/2028), 24G130 (30/04/2028), 24G330 (30/04/2028), 24G331 (30/04/2028), 24G333 (30/06/2028), 24I243 (31/07/2028), 24I245 (31/07/2028), 24I400 (31/07/2028), 24I402 (30/09/2028), 24I403 (30/09/2028), 24I404 (30/09/2028), 24I418 (30/09/2028), 24K161 (31/10/2028), 24K162 (31/10/2028), 24K163 (31/10/2028), 24K164 (30/11/2028), 24K165 (30/11/2028), 24K166 (30/11/2028), 24K167 (30/11/2028), 24K168 (30/09/2028), 25D674 (31/03/2029), 25D675 (31/03/2029), 25F174 (31/05/2030), 25F175 (31/05/2030), 25F263 (31/05/2030)
What this means, batches, details

Loading…

MHRA alert on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency

10 Dec 2025Wednesday 10 December 2025

open day ◀ ▶ 1 event
Medicines recall Amitriptyline Hydrochloride 10mg Tablets
Class 4 defect notification · 3 products · DMRC - 37698206 · PL: 43461/0054 · Flamingo Pharma UK Ltd · amitriptyline hydrochloride
Batches: 1404515 (31/12/2025), 1404539 (31/12/2025), 1404540 (31/12/2025), 1404546 (31/12/2025), 1404721 (31/03/2026), 1404722 (31/03/2026), 1404628 (28/02/2026), 1404630 (28/02/2026), 1404631 (28/02/2026), 1404632 (28/02/2026), 1404640 (28/02/2026), 1404641 (28/02/2026), 1404629 (28/02/2026), 1404615 (31/01/2026), 1404616 (31/01/2026), 1404626 (31/01/2026), 1404627 (31/01/2026), 1404724 (31/03/2026), 1404723 (30/04/2026)
What this means, batches, details

Loading…

MHRA alert on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency

4 Dec 2025Thursday 4 December 2025

open day ◀ ▶ 1 event · 1 important
Drug Safety Update Mesalazine and idiopathic intracranial hypertension
Idiopathic intracranial hypertension (IIH) has been very rarely reported in patients treated with mesalazine. Following a recent review, warnings for IIH are being added to the product information for…
What this means, batches, details

Loading…

Drug Safety Update on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency
← newer days older days →

In total 284 events.